Highlights

  • Arm closed at $244.79 on Thursday 15 October 2026, up $6.78, or 2.85%, at 4:00 p.m.
  • The shares therefore fell about 6.8% between the closes of 13 and 14 October before recovering part of that loss.
  • Arm licenses and markets CPU, GPU and neural processing unit designs, and the company is a subsidiary of SoftBank Group.
  • Product news continued alongside the litigation. Arm's newsroom lists a 13 October article by Mohamed Awad, executive vice president.

Arm Holdings (NASDAQ:ARM), the Cambridge-based designer of processor intellectual property, issued a statement on 13 October 2026 headlined "Arm welcomes favorable jury verdict in Qualcomm litigation". StockAnalysis, listing news headlines, said Arm reported that the jury found in its favour on four claims, while Qualcomm said the jury found that Arm breached a licence agreement.

Those two characterisations are not necessarily inconsistent, since a jury can decide different claims in different directions, but the available information do not set out the verdict form, any damages or the next procedural steps. Until the court record or the companies' filings are consulted, the commercial significance of the outcome cannot be quantified from the material available.

Share price reaction

Arm closed at $244.79 on Thursday 15 October 2026, up $6.78, or 2.85%, at 4:00 p.m. Eastern Time, In the reported figures. The previous close, on 14 October, was $238.01, and the close on 13 October was $255.39. A headline listed by the same page said the shares fell 2% to $250.33 after Qualcomm announced its jury win, an intraday figure.

The shares therefore fell about 6.8% between the closes of 13 and 14 October before recovering part of that loss. The sources do not attribute the full move to the verdict alone, and broader market conditions could have contributed.

Recent financial results

Arm reports on a fiscal year ending 31 March. For the first quarter of fiscal 2027, ended 30 June 2026, the company announced results on 29 July, describing a record first-quarter total revenue. The company's release pointed to a shareholder letter for figures, which StockAnalysis shows revenue of $1.289 billion, net income of $270 million and earnings per share of $0.25 for that quarter.

The preceding quarter, ended 31 March 2026, showed revenue of $1.490 billion, net income of $313 million and earnings per share of $0.29, while the quarter ended 31 December 2025 showed revenue of $1.242 billion. For the full fiscal 2026 year, StockAnalysis reports revenue of $4.92 billion, up 22.8%, and earnings of $904 million, up 14.1%.

Arm licenses and markets CPU, GPU and neural processing unit designs, and the company is a subsidiary of SoftBank Group. Revenue combines licensing and royalty income, although the split was not available in the available information.

Listing and index context

Product news continued alongside the litigation. Arm's newsroom lists a 13 October article by Mohamed Awad, executive vice president for cloud AI, on how AI agents are changing what central processing unit performance means, and in September the company announced an AI-native compute platform, an AGI CPU and Neoverse CSS N4. StockAnalysis also listed a Lattice collaboration with Arm on AI data centre infrastructure around 8 October. None has been quantified in revenue.

Arm's Nasdaq listing is an American depositary share arrangement, according to Wikipedia, and the company files Form 20-F and Form 6-K as a foreign private issuer. Arm is described by Wikipedia as a Nasdaq-100 component and appears in a StockAnalysis list of Nasdaq-100 stocks. Both are secondary sources, so Nasdaq's own constituent documentation is the authoritative reference. It does not appear in the S&P 500 list we reviewed.

What to watch next

Arm has announced that it will report second-quarter fiscal 2027 results; StockAnalysis gives the date as 4 November 2026 after market close, and the company's 5 October announcement is on its newsroom. Investors may look for any disclosure about the Qualcomm verdict, including whether either party files post-trial motions or an appeal, and for how licensing and royalty revenue evolve against the first-quarter figures above. Management commentary will also be useful context.